Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CERS Cerus Corp
- Stocks
- Healthcare
- NASDAQ: CERS
Price (delayed)
$1.36
Market cap
$259.98M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.1
Enterprise value
$338.84M
Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies
Highlights
CERS's EPS is up by 41% year-on-year and by 9% since the previous quarter
The company's net income rose by 40% YoY and by 9% QoQ
The quick ratio has declined by 11% since the previous quarter and by 7% year-on-year
Key stats
What are the main financial stats of CERS
Market
Valuations
Earnings
Shares outstanding
191.16M
Market cap
$259.98M
Enterprise value
$338.84M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.55
Price to sales (P/S)
1.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.64
Revenue
$206.78M
Gross profit
$125.31M
Operating income
-$12.1M
Net income
-$18.95M
EBIT
-$9.99M
EBITDA
-$5.95M
Free cash flow
$6.71M
Per share
Balance sheet
Liquidity
EPS
-$0.1
EPS diluted
-$0.1
Free cash flow per share
$0.04
Book value per share
$0.3
Revenue per share
$1.11
TBVPS
$1.1
Total assets
$206.78M
Total liabilities
$150.53M
Debt
$99.45M
Equity
$55.49M
Working capital
$91.83M
Debt to equity
1.79
Current ratio
2.32
Quick ratio
1.56
Net debt/EBITDA
-13.25
Margins
Efficiency
Dividend
EBITDA margin
-2.9%
Gross margin
60.6%
Net margin
-9.2%
Operating margin
-5.9%
Return on assets
-9.7%
Return on equity
-35.3%
Return on invested capital
-4.7%
Return on capital employed
-7.3%
Return on sales
-4.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CERS stock price
How has the Cerus stock price performed over time
Intraday
4.62%
1 week
4.62%
1 month
11.48%
1 year
-27.66%
YTD
-11.69%
QTD
-2.16%
Financial performance
How have Cerus's revenue and profit performed over time
Revenue
$206.78M
Gross profit
$125.31M
Operating income
-$12.1M
Net income
-$18.95M
Gross margin
60.6%
Net margin
-9.2%
Cerus's operating margin has surged by 53% YoY and by 17% QoQ
CERS's operating income is up by 49% year-on-year and by 15% since the previous quarter
Cerus's net margin has increased by 44% YoY and by 12% QoQ
The company's net income rose by 40% YoY and by 9% QoQ
Price vs fundamentals
How does CERS's price correlate with its fundamentals
Growth
What is Cerus's growth rate over time
Valuation
What is Cerus stock price valuation
P/E
N/A
P/B
4.55
P/S
1.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.64
CERS's EPS is up by 41% year-on-year and by 9% since the previous quarter
CERS's price to book (P/B) is 51% lower than its 5-year quarterly average of 9.2 and 19% lower than its last 4 quarters average of 5.6
CERS's equity is up by 12% year-on-year
The stock's price to sales (P/S) is 74% less than its 5-year quarterly average of 4.8 and 18% less than its last 4 quarters average of 1.5
CERS's revenue is up by 8% year-on-year and by 2.7% since the previous quarter
Efficiency
How efficient is Cerus business performance
CERS's return on sales has surged by 59% year-on-year and by 19% since the previous quarter
The ROIC has soared by 57% YoY and by 16% from the previous quarter
CERS's return on equity is up by 44% year-on-year and by 12% since the previous quarter
Cerus's return on assets has increased by 39% YoY and by 11% QoQ
Dividends
What is CERS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CERS.
Financial health
How did Cerus financials performed over time
CERS's total assets is 37% greater than its total liabilities
The quick ratio has declined by 11% since the previous quarter and by 7% year-on-year
CERS's total assets is up by 9% year-on-year and by 2.9% since the previous quarter
Cerus's debt is 79% higher than its equity
Cerus's debt to equity has decreased by 12% YoY but it has increased by 2.3% QoQ
CERS's equity is up by 12% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.